Aug 01, 2017
BioPharm International
The author outlines an analytical strategy for establishing similarity in biosimilar development and approval.
Aug 01, 2017
BioPharm International
Investigational failures and discrepancies can be avoided through the proper execution and documentation of investigations.
Aug 01, 2017
BioPharm International
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Aug 01, 2017
BioPharm International
Industry experts weigh in on best practices, challenges, and mutual recognition of cleaning validation standards.
Aug 01, 2017
BioPharm International
Media manufacturers are focused on reducing risk, improving quality and consistency, and managing costs.
Aug 01, 2017
BioPharm International
Improved resin chemistries and customized separation solutions are enabling more efficient separations.
Aug 01, 2017
BioPharm International
Amid debate about “fake news,” peer-review papers offer vital, objective insight.
Aug 01, 2017
BioPharm International
Despite some progress, the industry is still in a wait-and-see mode regarding the administration, Congress, and FDA.
Aug 01, 2017
BioPharm International
FDA urges manufacturers to seek fast approval of “high-need” generics and targeted therapies. 
native1_300x100
lorem ipsum